Shares of Torrent Pharmaceuticals jumped over 4 per cent on Thursday after the company reported 36.31 per cent rise in consolidated net profit for the quarter ended September.
The company's scrip gained 4.33 per cent to Rs 1,753.50 on the BSE.
At the NSE, it advanced 4.41 per cent to Rs 1,754.50.
Torrent Pharmaceuticals on Wednesday reported a 36.31 per cent rise in consolidated net profit to Rs 244 crore for the September quarter on robust sales in the domestic market.
The company had posted a net profit of Rs 179 crore for the corresponding period of the previous fiscal, Torrent Pharmaceuticals said in a BSE filing.
Consolidated revenue from operations stood at Rs 2,005 crore for the quarter under consideration as against Rs 1,894 crore for the same period last year.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app